Bringhen, S., Voorhees, P. M., Plesner, T., Mellqvist, U., Reeves, B., Sonneveld, P., . . . Richardson, P. G. (2021). Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: Long‐term survival follow‐up from the Phase II study O‐12‐M1. Br J Haematol.
Stile di citazione ChicagoBringhen, Sara, et al. "Melflufen Plus Dexamethasone in Relapsed/refractory Multiple Myeloma: Long‐term Survival Follow‐up From the Phase II Study O‐12‐M1." Br J Haematol 2021.
Citazione MLABringhen, Sara, et al. "Melflufen Plus Dexamethasone in Relapsed/refractory Multiple Myeloma: Long‐term Survival Follow‐up From the Phase II Study O‐12‐M1." Br J Haematol 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.